
Episode 13: You get blinatumomab! You get blinatumomab!
WolverHeme Happy Hour
00:00
The Importance of BFM in Adult Patients
There's an argument, you know, there's a strong argument for it. My unanswered question though, is like, if you're a hyper C VAD center, are you going to give a BFM style regimen that's going to be very challenging? Should patient should people change their strategy to E. Cog 2993 or E.Cog 1910 plus BLIN and somehow incorporate BLIN into their practice? Am I even asking a reasonable question because it's BLIN even feasible in those patients? I don't know. It's gonna be a challenges implementation for sites that don't currently use a BFM strategy for their ALS. This peer speculation tonight.
Transcript
Play full episode